Exon skipping oligos for DMD
Page 1 of 1
Exon skipping oligos for DMD
Jon Moulton Thu Apr 01, 2010 11:39 am
Wood MJA. Toward an oligonucleotide therapy for Duchenne muscular dystrophy: A complex development challenge. Sci. Transl. Med. 2010;2:25ps15.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
» In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52-Deficient mdx Mouse
» Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
» The exon 45 skipping therapy of induced pluripotent stem cells derived cardiomyocyte from the DMD patient with exon 46-55 deletion
» Designing Effective Antisense Oligonucleotides for Exon Skipping
» In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52-Deficient mdx Mouse
» Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
» The exon 45 skipping therapy of induced pluripotent stem cells derived cardiomyocyte from the DMD patient with exon 46-55 deletion
» Designing Effective Antisense Oligonucleotides for Exon Skipping
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum